Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Keratosis, Actinic 5Neoplasms 4Urinary Bladder Neoplasms 1Squamous Intraepithelial Lesions 1Solid Tumors Harboring NTRK Fusion 1Skin Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pain 1Obesity 1Nonmelanoma Skin Cancers 1Neoplasm Metastasis 1Mucositis 1Lung Neoplasms 1Leukemia 1Invasive Fungal Infections 1Infertility, Female 1Infertility 1Inappropriate Prescribing 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Basal Cell Nevus Syndrome 1Anemia 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 171Paclitaxel 129Radiotherapy 119Cisplatin 109Docetaxel 93Gemcitabine 81Erlotinib Hydrochloride 80Pemetrexed 78Bevacizumab 56Etoposide 41pembrolizumab 36Gefitinib 32Vinorelbine 31Topotecan 30Surveys and Questionnaires 29Irinotecan 28Radiosurgery 21Nivolumab 20Drug Therapy 20Magnetic Resonance Spectroscopy 18Cetuximab 18durvalumab 17Early Intervention, Educational 17Blood Specimen Collection 17Surgical Procedures, Operative 16Cyclophosphamide 16Celecoxib 15Ipilimumab 14Immunohistochemistry 14Filgrastim 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lung Neoplasms × Solutions × Clear all
NCT00210080 2015-09-04

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

Merck Sharp & Dohme LLC

Phase 3 Completed
700 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡